At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZLAB Zai Lab Ltd
Pre-Mkt 01-08 04:00:12 EST
19.03
+0.83
+4.56%
High19.32Low18.81Vol1.34M
Open19.14D1 Closing18.20Amplitude2.80%
Mkt Cap2.13BTradable Cap2.08BTotal Shares111.96M
T/O25.60MT/O Rate1.23%Tradable Shares109.37M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Zai Lab Initiated at Buy by UBS
Dow Jones  ·  04:25
Zai Lab Initiated at Buy by UBS
UBS Initiates Zai Lab at Buy With $35 Price Target
MT Newswires Live  ·  01-07 23:14
UBS Initiates Zai Lab at Buy With $35 Price Target
Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Volatility
Simply Wall St.  ·  01-06 14:13
Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Volatility
Asian Equities Traded in the US as American Depositary Receipts Climb in Friday Trading
MT Newswires Live  ·  01-02
Asian Equities Traded in the US as American Depositary Receipts Climb in Friday Trading
HK Stock Movement | Zai Lab (09688) Rises Over 4% in Early Trading as Breakthrough Schizophrenia Drug KAI JIE LE Gains Approval in China
Stock News  ·  2025-12-24
HK Stock Movement | Zai Lab (09688) Rises Over 4% in Early Trading as Breakthrough Schizophrenia Drug KAI JIE LE Gains Approval in China
Zai Lab Says New Drug Application for Schizophrenia Treatment Cobenfy Approved by China's National Medical Products Administration
MT Newswires Live  ·  2025-12-23
Zai Lab Says New Drug Application for Schizophrenia Treatment Cobenfy Approved by China's National Medical Products Administration
How Investors May Respond To Zai Lab (ZLAB) Advancing ZL-1503 Into Global Phase 1/1b Atopic Dermatitis Trial
Simply Wall St.  ·  2025-12-19
How Investors May Respond To Zai Lab (ZLAB) Advancing ZL-1503 Into Global Phase 1/1b Atopic Dermatitis Trial
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Ends Week Flat
MT Newswires Live  ·  2025-12-12
Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Ends Week Flat
How Investors Are Reacting To Zai Lab (ZLAB) Advancing ZL-1503 And Securing Key NRDL Renewals
Simply Wall St.  ·  2025-12-10
How Investors Are Reacting To Zai Lab (ZLAB) Advancing ZL-1503 And Securing Key NRDL Renewals
Zai Lab Begins Phase 1/1b Study of Atopic Dermatitis Therapy
MT Newswires Live  ·  2025-12-08
Zai Lab Begins Phase 1/1b Study of Atopic Dermatitis Therapy
Zai Lab Says China Renews 3 Medicines in 2025 National Reimbursement Drug List
MT Newswires Live  ·  2025-12-08
Zai Lab Says China Renews 3 Medicines in 2025 National Reimbursement Drug List
Zai Lab (09688) Grants Stock Options and Restricted Share Units
Stock News  ·  2025-12-03
Zai Lab (09688) Grants Stock Options and Restricted Share Units
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Q3 2025 Results and Pipeline Progress
Simply Wall St.  ·  2025-12-02
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Q3 2025 Results and Pipeline Progress
What Zai Lab (ZLAB)'s Q3 Results and Reaffirmed 2025 Guidance Mean for Shareholders
Simply Wall St.  ·  2025-12-01
What Zai Lab (ZLAB)'s Q3 Results and Reaffirmed 2025 Guidance Mean for Shareholders
Zai Lab (09688) Issues 2 Million Shares Under Equity Incentive Plans
Stock News  ·  2025-11-19
Zai Lab (09688) Issues 2 Million Shares Under Equity Incentive Plans
Zai Lab Ltd Announces Share Options and Restricted Share Units Grants
TIPRANKS  ·  2025-11-11
Zai Lab Ltd Announces Share Options and Restricted Share Units Grants
Zai Lab (09688) Grants Stock Options and Restricted Share Units
Stock News  ·  2025-11-11
Zai Lab (09688) Grants Stock Options and Restricted Share Units
Zai Lab Ltd (1ZLB) Gets a Buy from UBS
TIPRANKS  ·  2025-11-11
Zai Lab Ltd (1ZLB) Gets a Buy from UBS
Stock Track | Zai Lab Plummets 5.05% Pre-Market Amid Broader Decline in Hong Kong's Innovative Drug Sector
Stock Track  ·  2025-11-07
Stock Track | Zai Lab Plummets 5.05% Pre-Market Amid Broader Decline in Hong Kong's Innovative Drug Sector
Hong Kong Stock Connect Innovative Drug Sector Declines in Afternoon Session, Zai Lab Plunges 10%, 520880 Drops 2% Below 10-Day Moving Average, Intraday Premium Surges
Deep News  ·  2025-11-07
Hong Kong Stock Connect Innovative Drug Sector Declines in Afternoon Session, Zai Lab Plunges 10%, 520880 Drops 2% Below 10-Day Moving Average, Intraday Premium Surges

Introduction

Company Name.
Zai Lab Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Issue price:
--